NPPA approves up to 50% price hike for critical medicines and vaccines

To combat severe domestic shortages driven by surging platinum and API costs, the NPPA has approved a one-time 50% price increase for critical chemotherapy drugs, anti-tetanus injections, and essential childhood vaccines.